Biotech

All Articles

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy medication, touts FDA run

.Our team actually know that Takeda is actually wishing to find a course to the FDA for epilepsy med...

VBI Vaccines apply for insolvency, finds asset sale

.Immunology biotech VBI Vaccinations is actually veering alarmingly near to the point of no return, ...

Celldex anti-cKIT antibody minimize hives in yet another period 2 study

.It is actually difficult to muscle in on an area as reasonable as immunology, however Celldex Thera...

Boehringer provides to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs as well as a preclini...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's condition medicine performed not aid clients obtain remission in a stag...

Cognition's stage 2 sparkle data tarnish Alzheimer's prospect

.Knowledge Therapeutics' stage 2 SHINE test has actually taken a number of the gloss off the Alzheim...

BMS axes bispecific months after submitting to operate period 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that supervised Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers...

Asarina to close after initiatives to companion Tourette's medicine stop working

.After connecting to more than 200 providers to partner a Tourette syndrome treatment that showed th...